A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation

American Journal of Transplantation

Volumn 6, Issue 7, 2006, Pages 1666-1672

  Grenda, R ^a   Watson, A ^b   Vondrak, K ^c   Webb, N J A ^d   Beattie, J ^e   Fitzpatrick, M ^f   Saleem, M A ^g   Trompeter, R ^h   Milford, D V ⁱ   Moghal, N E ^j   Hughes, D ^k   Perner, F ^l   Friman, S ^m   Van Damme Lombaerts, R ⁿ   Janssen, F ^o  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^h GREAT ORMOND STREET HOSPITAL   (United Kingdom)

ⁱ BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^j ROYAL VICTORIA INFIRMARY   (United Kingdom)

^k ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^l SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^m SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

more..

Author keywords

Basiliximab; Efficacy; Kidney transplant; Tacrolimus

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; BASILIXIMAB; METHYLPREDNISOLONE; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ANEMIA; ARTICLE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; OPEN STUDY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SCHOOL CHILD; URINARY TRACT INFECTION; VOMITING;

ADOLESCENT; ANTIBODIES, MONOCLONAL; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; RECOMBINANT FUSION PROTEINS; TACROLIMUS;

EID: 33745364781     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01367.x     Document Type: Article

References (22)

1. Tejani A Ho PL Emmett L Stablein DM. Reduction in acute rejections decreases chronic rejection graft failure in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Transplant 2002 2: 142 147.
2. Trompeter R Filler G Webb NJA et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002 17: 141 149.
3. Shapiro R Scantlebury VP Jordan ML et al. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999 67: 299 303.
4. Neu AM Ho PL Fine RN Furth SL Fivush BA. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study. Pediatr Transplant 2003 7: 217 222.
5. Jensen S Jackson EC Riley L Reddy S Goebel J. Tacrolimus based immunosuppression with steroid withdrawal in pediatric kidney transplantation - 4-year experience at a moderate-volume center. Pediatr Transplant 2003 7: 119 124.
6. Filler G Webb NJA Milford DV et al. Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatr Transplant 2005 9: 498 503.
7. Nashan B Moore R Amlot P Schmidt A-G Abeywickrama K Saulillou J-P. Randomized trial of basiliximab versus placebo for control of acute rejection in renal allograft recipients. Lancet 1997 350: 1193 1198.
8. Kahan BD Rajagopalan PR Hall ML. Reduction in the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody. Transplantation 1999 67: 276 284.
9. Vincenti F Kirkman R Light S et al. for the Daclizumab Triple Therapy Study Group. Interleukin-2 receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998 338: 161 165.
10. Vester U Kranz B Testa G. Efficacy and tolerability of interleukin-2 receptor blockage with basiliximab in pediatric renal transplant recipients. Pediatr Transplant 2001 5: 297 301.
11. Offner G Broyer M Niaudet P et al. A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients. Transplantation 2002 74: 961 966.
12. Swiatecka-Urban A Garcia C Feuerstein D et al. Basiliximab induction improves the outcome of renal transplants in children and adolescents. Pediatr Nephrol 2001 16: 693 696.
13. Pape L Strehlau J Henne T et al. Single centre experience with basiliximab in paediatric renal transplantation. Nephrol Dialysis Transplant 2002 17: 276 280.
14. Racusen LC Solez K Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55: 713 723.
15. Schwartz GJ Haycock GB Edelmann CM Jr. Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976 58: 259 263.
16. Food and Drug Administration. COSTART: Coding symbols for thesaurus of adverse reaction terms. 3rd ed. Rockville, MD: Department of Health and Human Services, Food and Drug Administration, Center for Durgs and Biologics, 1989.
17. Smith JM Nemeth TL McDonald RA. Current immunosuppressive agents: Efficacy, side effects, and utilization. Pediatr Clin North Am 2003 50: 1283 1300.
18. Di Filippo S. Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation. Pediatr Transplant 2005 9: 373 380.
19. Sifontis NM Benedetti E Vasquez EM. Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients. Transplant Proc 2002 34: 1730 1732.
20. Ojogho O Sahney S Cutler D et al. Mycophenolate mofetil in pediatric renal transplantation: Non-induction vs. induction with basiliximab. Pediatr Transplant 2005 9: 80 83.
21. Shapiro R Nalesnik M McCauley J et al. Post-transplant lymphoproliferative disorders (PTLD) in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 68: 1851 1854.
22. Cherikh WS Kauffman HM McBride MA Maghirang J Swinnen LJ Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003 76: 1289 1293.